L. S. Hermann

699 total citations
16 papers, 534 citations indexed

About

L. S. Hermann is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, L. S. Hermann has authored 16 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pharmacology. Recurrent topics in L. S. Hermann's work include Metabolism, Diabetes, and Cancer (10 papers), Diabetes Treatment and Management (8 papers) and Pharmacology and Obesity Treatment (6 papers). L. S. Hermann is often cited by papers focused on Metabolism, Diabetes, and Cancer (10 papers), Diabetes Treatment and Management (8 papers) and Pharmacology and Obesity Treatment (6 papers). L. S. Hermann collaborates with scholars based in Sweden, Denmark and Netherlands. L. S. Hermann's co-authors include M Iversen, Arne Melander, Bengt Scherstén, Thomas Kjellström, Johan Karlsson, Bo Hedbäck, Peter Nilsson‐Ehle, Folke Lindgärde, Gunnar Lindberg and Jonas Ranstam and has published in prestigious journals such as The Lancet, Diabetologia and Diabetic Medicine.

In The Last Decade

L. S. Hermann

16 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. S. Hermann Sweden	10	219	141	117	80	76	16	534
Aaron Grossman United States	14	82 0.4×	118 0.8×	100 0.9×	109 1.4×	59 0.8×	23	588
Per Anders Dahlberg Sweden	21	698 3.2×	125 0.9×	58 0.5×	192 2.4×	71 0.9×	37	976
M Messina Italy	11	271 1.2×	83 0.6×	127 1.1×	103 1.3×	39 0.5×	22	492
M. Armitage United Kingdom	10	233 1.1×	64 0.5×	93 0.8×	101 1.3×	55 0.7×	23	490
Leena Anttila Finland	19	228 1.0×	179 1.3×	35 0.3×	76 0.9×	65 0.9×	48	1.1k
Inge Tygstrup Denmark	13	72 0.3×	145 1.0×	158 1.4×	87 1.1×	43 0.6×	31	649
Gerald S. Kidd United States	16	452 2.1×	180 1.3×	153 1.3×	116 1.4×	32 0.4×	33	832
Ichiro Iwamoto Japan	16	97 0.4×	147 1.0×	115 1.0×	77 1.0×	146 1.9×	50	677
Emõke Endreffy Hungary	16	47 0.2×	141 1.0×	43 0.4×	104 1.3×	67 0.9×	38	693
L.W. Eddie Australia	14	134 0.6×	137 1.0×	83 0.7×	34 0.4×	21 0.3×	21	776

Countries citing papers authored by L. S. Hermann

Since Specialization

Citations

This map shows the geographic impact of L. S. Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. S. Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. S. Hermann more than expected).

Fields of papers citing papers by L. S. Hermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. S. Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. S. Hermann. The network helps show where L. S. Hermann may publish in the future.

Co-authorship network of co-authors of L. S. Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of L. S. Hermann. A scholar is included among the top collaborators of L. S. Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. S. Hermann. L. S. Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hermann, L. S., Gunnar Lindberg, Ulf Lindblad, & Arne Melander. (2002). Efficacy, effectiveness and safety of sulphonylurea–metformin combination therapy in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 4(5). 296–304. 11 indexed citations

Hermann, L. S., et al.. (2001). Long‐term glycaemic improvement after addition of metformin to insulin in insulin‐treated obese type 2 diabetes patients. Diabetes Obesity and Metabolism. 3(6). 428–434. 27 indexed citations

Hermann, L. S.. (2000). Optimising Therapy for Insulin-Treated Type 2 Diabetes Mellitus. Drugs & Aging. 17(4). 283–294. 6 indexed citations

Hermann, L. S., Jonas Ranstam, Stein Vaaler, & Arne Melander. (1999). Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes. Diabetes Obesity and Metabolism. 1(4). 227–232. 10 indexed citations

Hermann, L. S. & Arne Melander. (1999). [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].. PubMed. 96(50). 5616–9. 1 indexed citations

Hermann, L. S., et al.. (1995). Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations. A Double-Blind Controlled Study. The Endocrinologist. 5(2). 161–161. 6 indexed citations

Hermann, L. S., Bengt Scherstén, & Arne Melander. (1994). Antihyperglycaemic Efficacy, Response Prediction and Dose—Response Relations of Treatment with Metformin and Sulphonylurea, Alone and in Primary Combination. Diabetic Medicine. 11(10). 953–960. 67 indexed citations

Hermann, L. S., et al.. (1991). Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles. European Journal of Clinical Pharmacology. 41(3). 263–265. 30 indexed citations

Hermann, L. S., Thomas Kjellström, & Peter Nilsson‐Ehle. (1991). Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non-insulin-dependent diabetes mellitus.. PubMed. 17(1 Pt 2). 174–9. 16 indexed citations

10.

Hermann, L. S., et al.. (1991). Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus.. PubMed. 17(1 Pt 2). 201–8. 20 indexed citations

11.

Hedbäck, Bo & L. S. Hermann. (1984). Antihypertensive Effect of Verapamil in Patients with Newly Discovered Mild to Moderate Essential Hypertension. Acta Medica Scandinavica. 215(S681). 129–135. 12 indexed citations

12.

Hellgren, Lars & L. S. Hermann. (1983). Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation.. PubMed. 167(5). 267–72. 5 indexed citations

13.

Hermann, L. S., S. Peter Magnusson, Burkhard Möller, et al.. (1981). Lactic Acidosis during Metformin Treatment in an Elderly Diabetic Patient with Impaired Renal Function. Acta Medica Scandinavica. 209(1-6). 519–520. 9 indexed citations

14.

Bj�rntorp, P., et al.. (1978). Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus. Diabetologia. 15(2). 95–98. 13 indexed citations

15.

Hermann, L. S., et al.. (1973). THE INFLUENCE OF PHENFORMIN ON LACTATE METABOLISM IN DIABETIC PATIENTS IN RELATION TO HYPOXIA AND EXERCISE. Acta Medica Scandinavica. 194(1-6). 111–116. 3 indexed citations

16.

Hermann, L. S. & M Iversen. (1968). DEATH DURING THERAPEUTIC STARVATION. The Lancet. 292(7561). 217–217. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact